Abbott (ABT) Reports Data Demonstrating Abbott's FreeStyle Libre 3 System is Most Accurate 14-Day Continuous Glucose Monitor

Go back to Abbott (ABT) Reports Data Demonstrating Abbott's FreeStyle Libre 3 System is Most Accurate 14-Day Continuous Glucose Monitor
Abbott Laboratories (NYSE: ABT) Delayed: 108.93 --0 (-0%)
Previous Close $108.93    52 Week High $46.38 
Open $108.93    52 Week Low $36.00 
Day High $108.93    P/E 72.62 
Day Low $108.93    EPS $1.50 
Volume 119